Start a free trial
Menu

AMedP-4.8

AMedP-4.8 pre- and post-deployment health assessments

National military medical services and physicians running the individual pre- and post-deployment health assessment that NATO nations agreed to under STANAG 2235

AMedP-4.8 sets the minimum health data NATO nations collect when assessing an individual service member before and after a NATO deployment, under the agreement recorded in STANAG 2235.

Edition
A
Published
2024-09

What it is

AMedP-4.8, "Pre- and post-deployment health assessment," is the NATO Allied Medical Publication that sets the minimum information a nation collects when assessing an individual service member's health immediately before and after a NATO deployment. This is Edition A, Version 3, promulgated 11 September 2024, superseding the previous version of the same edition. The publication's own aim is "to ensure that pre- and post-deployment health assessments are conducted for personnel participating in NATO operations, that these assessments include at least a minimum set of data elements, and that proper action is made on medical findings to ensure that deployed personnel are in good health."

It exists because multinational deployments assume every contributing nation's troops meet a comparable health baseline. As the document puts it, "this emphasizes the need for the alliance to ensure that the same minimum standards are met by all nations," whichever nation is providing the troops. Nations agree to use the publication through a separate NATO agreement: "the agreement of nations to use this publication is recorded in STANAG 2235." AMedP-4.8 is the content; STANAG 2235 is the cover that gives it force among the nations that ratify it.

Who runs the assessment, and who does not

The document is written for nations, and through them for the physicians, medical planners and medical personnel who carry out the two assessments. It never addresses a "supplier," "manufacturer" or "contract," and it sets no obligation reaching a defence contractor directly. Three nations recorded reservations against the underlying agreement at promulgation: Canada notes a difference in its own recording terminology, Latvia excepts two logistic points from its implementation, and the United States notes that "while the STANAG clearly specifies that its requirements are minimum essential information requirements, the STANAG does not fully address information requirements which through USA experience are critical to adequate pre-and post-deployment health surveillance," collecting the same minimum data across several of its own forms and systems rather than a single one.

Pre-deployment health assessment

The pre-deployment assessment "serves two purposes": it "assists commanders by providing realistic information on health as a prerequisite for fighting ability, while giving the ability to perform selection and treatment in order to increase force health prior to deployment," and, where the finding is acted on, it reduces "the workload of the deployed health services" and preserves capacity "needed to cope with battle injuries." The assessment records identifying and deployment information about the service member alongside individual-level health information relevant to deployability, gathered "by interview or self-declaration" and "kept in a prepared format." A physician then makes the final assessment, and "the medical decision should be documented as part of the troop preparation process."

Post-deployment health assessment

After the operation, "a risk based post-deployment health assessment should be performed, in order to identify health problems and/or exposures that could potentially result in health problems." The document is explicit that this is not only for the individual: "this health assessment will form the basis for providing the soldier with health support as needed," and "it feeds into the process of continuously improving military medical services, including force health protection." Medical personnel collect deployment-related information through interview, covering matters such as duty restrictions and possible exposures, and record whether the individual needs referral or further debriefing.

Where the record goes, and its one data-protection line

The document says specifically where the post-deployment record lives and under what constraint: "the made medical assessments should be documented in the soldiers' medical file and be fed into the lessons learned process of the medical services, while at all times meeting legislative demands on the protection of the individuals' medical information." It names no specific data-protection regime of its own; the obligation is to meet whatever legislative demands already apply, not a NATO-specified standard for handling the data. Beyond that clause, AMedP-4.8 does not describe retention periods or further sharing of the assessment.

How it's evaluated

There is no certification, accreditation or audit scheme here, because the document assesses an individual, not an organisation. Pre-deployment, "a final assessment of the individual soldiers' health should be made by a physician." Post-deployment, the document says the resulting assessment should "be documented in the soldiers' medical file and be fed into the lessons learned process of the medical services." No accredited body, notified body, government surveillance visit or customer audit appears anywhere in the text, and no organisation, a nation's medical service included, is described as certified against it.

Standards it references

AMedP-4.8's only cross-reference is STANAG 2235: "the agreement of nations to use this publication is recorded in STANAG 2235." STANAG 2235 is the standardization agreement this publication sits under, not a separate piece of background reading - it is how AMedP-4.8 acquires force among the nations that ratify it.

How we help

The work AMedP-4.8 describes - a physician's pre-deployment assessment, a post-deployment interview, and the resulting entry in a service member's own medical file - is clinical work carried out by a nation's military medical service, not something a compliance platform performs. What that kind of work still needs, separate from the clinical content itself, is a documented procedure for running the assessments consistently, training records for the personnel who run them, and an evidence trail showing the process was followed as designed.

ComplyTrain gives an organisation supporting that process one auditable place to hold those procedures, training records and corrective-action history generally. It does not perform, store or manage the health assessment itself, and it holds no service member's medical or health data - that stays in the systems this document describes, under whatever legislative protection already applies.

Which standardization agreements and Allied Publications apply to a given defence programme is set by the contract and the customer's quality clause, not by us. Browse the explorer to see what sits alongside AMedP-4.8 and STANAG 2235, and talk to us about the evidence trail once you know which ones are in your contract.

Questions

Is AMedP-4.8 mandatory?

It binds through the nations' agreement recorded in STANAG 2235, not through a contract clause reaching a supplier. A nation can also record a reservation against parts of the agreement, as three did when this edition was promulgated, so "mandatory" is a question about a specific nation's ratification rather than a general one.

Can an organisation be certified to AMedP-4.8?

No. The document describes a physician's or medical team's assessment of an individual service member, documented in that person's own medical file. It names no accredited certification body, notified body or audit scheme, and no organisation can hold a certificate against it.

What is the difference between AMedP-4.8 and STANAG 2235?

STANAG 2235 is the NATO Standardization Agreement recording nations' commitment to use this publication; AMedP-4.8 is the Allied Medical Publication that actually sets the minimum data and process for the pre- and post-deployment health assessment.

Does AMedP-4.8 apply to defence suppliers?

Not directly. It addresses what a nation's own military medical services and physicians do around an individual's deployment. It does not use the words "supplier," "manufacturer" or "contract," and it sets no obligation reaching a defence company.

What changed in this edition of AMedP-4.8?

This is Edition A, Version 3, promulgated 11 September 2024. The letter of promulgation states that it "supersedes AMedP-4.8, Edition A, Version 2, which shall be destroyed in accordance with the local procedure for the destruction of documents," but the document does not itself describe what changed between the two versions.